research feed

Every NR4A2 paper, in plain English

PubMed and the Europe PMC preprint servers are queried daily for NR4A2 and NURR1, back to the earliest records. Each abstract is summarised locally by Qwen3.6 35B and tagged by relevance to a parent of an NR4A2 child. Source links go straight to the paper.

subscribe (Atom feed) · high and medium relevance only

registered clinical trials

Every ClinicalTrials.gov study whose record mentions NR4A2 or NURR1. Most use NURR1 as a Parkinson's biomarker rather than testing anything for this syndrome, so read the conditions line. Studies still open come first. Last checked 2026-09-14.

completed or inactive (4) ›
medium2009-03-11 · Neuroscience letters

Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.

Sleiman PM, Healy DG, Muqit MM, Yang YX, Van Der Brug M, Holton JL, Revesz T, Quinn NP, Bhatia K, Diss JK, Lees AJ, Cookson MR, Latchman DS, Wood NW

This study identifies a specific NR4A2 mutation found in Parkinson's disease patients that reduces gene expression and disrupts nervous system development pathways. The findings confirm that this genetic variant impairs the protein's ability to protect neurons from stress, linking reduced NR4A2 levels directly to cellular dysfunction.

  • Researchers screened 409 Parkinson's patients and found a novel NR4A2 mutation in the gene's regulatory region.
  • The mutation significantly reduces NR4A2 mRNA expression in both cell cultures and human brain tissue.
  • Reduced NR4A2 levels downregulate genes critical for nervous system development and synaptic transmission.
  • The mutant protein loses its ability to protect neurons against apoptotic stress compared to the normal version.
high2009-01-21 · European journal of human genetics : EJHG

An 8.9 Mb 19p13 duplication associated with precocious puberty and a sporadic 3.9 Mb 2q23.3q24.1 deletion containing NR4A2 in mentally retarded members of a family with an intrachromosomal 19p-into-19q between-arm insertion.

Lybaek H, Ørstavik KH, Prescott T, Hovland R, Breilid H, Stansberg C, Steen VM, Houge G

This study identifies a specific microdeletion on chromosome 2q that removes the NR4A2 gene in family members with intellectual disability, providing direct human genetic evidence linking NR4A2 loss to neurodevelopmental issues. It also documents a separate chromosomal duplication associated with precocious puberty, though this finding does not involve NR4A2.

  • A 3.9 Mb deletion on chromosome 2q removes NR4A2 in relatives with intellectual disability.
  • This confirms NR4A2 haploinsufficiency contributes to the neurodevelopmental phenotype.
  • An unrelated 19p duplication caused precocious puberty but did not involve NR4A2.
  • Gene expression analysis showed limited impact from the duplication, excluding it as a cause for early puberty.
medium2009-01-14 · Development (Cambridge, England)

Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression.

Jacobs FM, van Erp S, van der Linden AJ, von Oerthel L, Burbach JP, Smidt MP

This study identifies Pitx3 as a critical partner that activates Nurr1 (NR4A2) to drive the development of dopamine-producing neurons. It shows that without Pitx3, Nurr1 remains inactive, but blocking specific repressive mechanisms can restore its function.

  • Pitx3 and Nurr1 work together to activate genes necessary for dopamine neuron development.
  • Nurr1 alone cannot fully activate these genes; it requires Pitx3 for complete function.
  • Pitx3 removes a repressor complex that normally keeps Nurr1 inactive.
  • Blocking this repression restores gene activity even without Pitx3 present.
medium2009-01-07 · Neurological research

Role of Nurr1 and Ret in inducing rat embryonic neural precursors to dopaminergic neurons.

Li L, Su Y, Zhao C, Xu Q

This study shows that Nurr1 and Ret work together in rat brain cells to help develop dopamine-producing neurons. Nurr1 drives the production of these specific nerve cells, while Ret helps them mature by increasing markers associated with dopamine function.

  • Nurr1 increases the number of developing dopamine neurons in rat embryonic cells.
  • Ret expression depends on Nurr1 but does not further increase neuron numbers.
  • Ret promotes neuronal maturation by upregulating the dopamine transporter gene.
  • The findings rely entirely on rat cell cultures, not human patients.
medium2008-12-01 · Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

[Association of the polymorphisms in NURR1 gene with Parkinson's disease].

Wu Y, Peng R, Chen W, Zhang J, Li T, Wang Y, Gou Y, Yuan G

This study finds that a specific genetic variation in the NR4A2 gene is more common in people who develop Parkinson's disease before age 50. The research does not identify any link between this gene variant and other forms of Parkinson's or general population risk.

  • The IVS6+18insG variant links to early-onset Parkinson's under age 50.
  • No association exists for the c.-2922(C)2-3 promoter site.
  • Study focuses on Han Chinese patients and controls.
  • Findings do not apply to NR4A2 developmental syndromes.
lower-relevance papers (35) ›
low2009-03-28 · Genomics

Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.

Colak D, Kaya N, Al-Zahrani J, Al Bakheet A, Muiya P, Andres E, Quackenbush J, Dzimiri N

This study analyzes gene expression in heart tissue from patients with end-stage dilated cardiomyopathy and finds that the NR4A2 gene is significantly down-regulated. The research identifies broad changes in energy metabolism and cell death pathways but does not investigate the functional role of NR4A2 or its connection to neurological conditions.

  • NR4A2 expression decreases by 4.8-fold in heart tissue from patients with dilated cardiomyopathy.
  • The study focuses on cardiac pathology, not neurological development or dopaminergic function.
  • No clinical implications for NR4A2-related syndromes are established or discussed.
  • NR4A2 is listed as having no clearly defined cardiac-related function in this context.
low2009-03-24 · Experimental cell research

Generation and properties of a new human ventral mesencephalic neural stem cell line.

Villa A, Liste I, Courtois ET, Seiz EG, Ramos M, Meyer M, Juliusson B, Kusk P, Martínez-Serrano A

Researchers create a stable human neural stem cell line that differentiates into dopamine-producing neurons expressing NR4A2 (NURR1) and other midbrain markers. This cell line serves as an in vitro model for studying dopaminergic neuron development and testing potential therapies for Parkinson's disease.

  • The hVM1 cell line is derived from human ventral mesencephalon neural stem cells.
  • Differentiated cells produce dopamine and express key midbrain markers like NURR1.
  • The model supports preclinical drug testing for Parkinson's disease cell replacement.
  • This is a basic science tool, not a clinical treatment or genetic study.
low2009-03-03 · BMC neuroscience

Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression.

Montzka K, Lassonczyk N, Tschöke B, Neuss S, Führmann T, Franzen R, Smeets R, Brook GA, Wöltje M

Human bone marrow stem cells naturally express many genes typically thought to be specific to nerve cells, even before being treated to become nerve-like. This variation between donors means results from stem cell studies may not be reliable or reproducible, which affects research into using these cells for treating neurological conditions.

  • Undifferentiated MSCs express neural markers naturally
  • Donor differences cause inconsistent results
  • Marker expression varies across individuals
  • This undermines claims of true neural differentiation
  • Donor selection is critical for reliable studies
low2009-03-01 · Journal of neuroscience research

Immunocytochemical expression of dopamine-related transcription factors Pitx3 and Nurr1 in prenatally stressed adult rats.

Katunar MR, Saez T, Brusco A, Antonelli MC

Prenatal stress in rats increases the levels of dopamine-regulating proteins Nurr1 and Pitx3 in specific brain regions, likely as a compensatory response to reduced dopamine signaling. This study provides no evidence for human treatment or genetic mechanisms relevant to NR4A2 syndrome.

  • Prenatal stress alters dopamine-related protein levels in adult rat brains.
  • Nurr1 and Pitx3 expression increases in the ventral tegmental area of stressed rats.
  • No changes occur in the substantia nigra region of these animals.
  • Increased proteins likely compensate for reduced dopamine release caused by stress.
  • The study uses only rat models with no human clinical data.
low2009-03-01 · Archives of histology and cytology

Expression of the nerve growth factor-induced gene B-beta in the developing rat brain and retina.

Li Y, Ohashi R, Naito M

This study maps where and when the NR4A2 protein appears in developing rat brains and retinas, showing it is present in non-dividing neurons during their final maturation stages. It confirms that NR4A2 expression coincides with post-mitotic differentiation rather than cell proliferation in these specific brain regions.

  • NR4A2 protein appears in rat midbrain neurons starting at 12 days of gestation.
  • Expression increases in the neocortex, thalamus, and hypothalamus during fetal development.
  • NR4A2-positive cells are not dividing, indicating a role in neuronal maturation.
  • The study uses standard animal models without testing any treatments or interventions.
low2009-03-01 · Human mutation

Haplotypes of the NR4A2/NURR1 gene and cardiovascular disease: the Rotterdam Study.

Kardys I, van Tiel CM, de Vries CJ, Pannekoek H, Uitterlinden AG, Hofman A, Witteman JC, de Maat MP

This study finds no link between common variations in the NR4A2 gene and major cardiovascular events like heart attacks or stroke in older adults. While some genetic variants show weak associations with blood pressure and cholesterol levels, they do not predict coronary disease or arterial plaque buildup.

  • NR4A2 haplotypes are not associated with coronary heart disease events.
  • No link exists between NR4A2 variants and carotid artery thickness or plaques.
  • Some variants correlate weakly with blood pressure and HDL cholesterol levels.
  • The study focuses on cardiovascular health, not neurological development.
  • Results do not inform the neurodevelopmental phenotype of NR4A2 syndrome.
low2009-02-24 · Neuroimmunomodulation

Nurr1 expression and its modulation in microglia.

Fan X, Luo G, Ming M, Pu P, Li L, Yang D, Le W

This study shows that Nurr1 is present in mouse microglia and increases when these immune cells are activated by inflammation. The research identifies specific cellular pathways that control this increase but does not test any treatments or involve human patients.

  • Nurr1 exists in mouse microglia, not just dopaminergic neurons.
  • Inflammatory stimulation significantly increases Nurr1 expression in these cells.
  • Specific signaling pathways modulate Nurr1 levels and location within the cell.
  • The study uses only cultured mouse cells with no clinical application.
low2009-02-18 · Reproduction (Cambridge, England)

Rapid effects of LH on gene expression in the mural granulosa cells of mouse periovulatory follicles.

Carletti MZ, Christenson LK

This study identifies rapid gene expression changes in mouse ovarian cells following luteinizing hormone stimulation, highlighting the immediate role of transcription factors like Nr4a2 in ovulation and luteinization processes. It demonstrates that Nr4a2 is among the earliest genes activated to initiate downstream cellular responses necessary for follicle rupture and corpus luteum formation.

  • Study uses mouse periovulatory granulosa cells, not human tissue or patients.
  • Nr4a2 expression increases rapidly within one hour of LH surge stimulation.
  • Research focuses on ovulation mechanics rather than neurodevelopmental syndromes.
  • No clinical implications or treatments for NR4A2-related disorders are discussed.
low2009-02-12 · Journal of molecular endocrinology

Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice.

Spyroglou A, Manolopoulou J, Wagner S, Bidlingmaier M, Reincke M, Beuschlein F

This study in mice shows that the gene NR4A2 (also called Nurr1) is quickly turned on by angiotensin II, which triggers aldosterone production. The enzyme needed to make aldosterone, Cyp11b2, increases rapidly and is tightly linked to Nurr1 activity. These findings suggest Nurr1 plays a direct role in controlling aldosterone release in response to stress signals.

  • NR4A2/Nurr1 is rapidly activated by angiotensin II in adrenal cells
  • Cyp11b2, the key enzyme for aldosterone, increases quickly after stimulation
  • Nurr1 induction correlates with increased aldosterone output
  • Sodium suppression reduces all steroidogenic genes, including Cyp11b2
  • Nurr1 is specifically induced by angiotensin II, not by sodium
low2009-01-22 · Blood

Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR.

Wang T, Jiang Q, Chan C, Gorski KS, McCadden E, Kardian D, Pardoll D, Whartenby KA

Blocking a specific gene called MINOR prevents dendritic cells from dying after activation, which significantly improves the effectiveness of vaccines made from these cells. This finding relies on cell culture experiments and does not involve human patients or direct treatment for NR4A2-related syndromes.

  • MINOR is a gene that triggers death in activated dendritic cells.
  • Inhibiting MINOR extends the lifespan of these immune cells.
  • Extended cell life enhances the potency of experimental vaccines.
  • The study uses lentiviral vectors to block MINOR expression.
  • Results are based on in vitro models, not human clinical data.
low2009-01-10 · Neuroscience

Expression of layer-specific markers in the adult neocortex of BCNU-Treated rat, a model of cortical dysplasia.

Moroni RF, Inverardi F, Regondi MC, Watakabe A, Yamamori T, Spreafico R, Frassoni C

This study uses a rat model to map how cortical layers become disorganized in brain malformations, identifying specific markers for different neuron types. It does not involve NR4A2, human patients, or potential treatments for this syndrome.

  • The research focuses on general cortical dysplasia, not NR4A2-related syndromes.
  • It uses a rat model treated with BCNU to mimic brain malformations.
  • No human data, genetic findings, or therapeutic insights are provided.
  • The work is basic neuroscience with no direct clinical application.
low2009-01-01 · Cytotherapy

A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy.

Yang KL, Chen MF, Liao CH, Pang CY, Lin PY

Researchers isolate stem cells from human wisdom teeth and demonstrate that transplanting these cells into rats with stroke-like brain injuries improves neurological recovery. The study confirms that these specific neural stem cells survive transplantation and offer therapeutic potential for stroke in an animal model.

  • Stem cells are successfully isolated from human wisdom teeth using a simple culture method.
  • Transplanted cells survive in the brains of rats with induced stroke injuries.
  • Treated rats show significant neurological recovery compared to untreated controls.
  • The study focuses on stroke therapy, not NR4A2-related syndromes or Parkinson's disease.
low2009-01-01 · Advances in experimental medicine and biology

Terminal differentiation ofmesodiencephalic dopaminergic neurons: the role of Nurr1 and Pitx3.

Smidt MP, Burbach JP

This paper identifies Nurr1 and Pitx3 as essential transcription factors that drive the final maturation of dopaminergic neurons in the midbrain. It establishes a molecular mechanism for how these proteins work together to ensure proper neuronal development.

  • Nurr1 and Pitx3 are critical for terminal differentiation of mesodiencephalic dopaminergic neurons.
  • The study defines the specific genetic pathway controlling this developmental stage.
  • Findings are based on molecular biology mechanisms without human clinical data.
low2009-01-01 · TSitologiia i genetika

[Differentiation of dofaminergic neurons from the human embryonal nerve cells in culture].

Tsymbaliuk VI, Vasyl'ieva IH, Oleksenko NP, Chopyk NH, Tsiubko OI, Halanta OS

Researchers successfully increased the proportion of dopamine-producing neuron precursors in cultured human embryonic nerve tissue by adjusting specific growth conditions. This process confirms that early developmental markers fade while key functional markers rise, demonstrating a method to enrich cell populations for potential future transplantation therapies.

  • Dopaminergic neuron precursor levels increased significantly from 5.6% to 23.5% in experimental cultures.
  • Control samples showed only a modest increase to 8.1%, highlighting the effectiveness of the specific culture conditions.
  • Gene expression analysis confirmed differentiation by tracking the disappearance of early factors and rise of TH.
  • The study demonstrates a protocol for enriching human embryonic tissue with cells suitable for neurotransplantation.
low2009-01-01 · Drug discovery today. Disease mechanisms

NR4A Orphan Nuclear Receptors in Cardiovascular Biology.

Zhao Y, Bruemmer D

This review describes the general molecular functions of NR4A receptors in cardiovascular biology, focusing on their role in vascular remodeling and atherosclerosis. It does not provide specific information about NR4A2-related neurodevelopmental syndromes or potential treatments for your child.

  • NR4A receptors regulate genes involved in vascular biology and metabolism.
  • The paper focuses on cardiovascular mechanisms, not neurological development.
  • No clinical data or treatment implications for NR4A2 syndrome are presented.
low2008-12-27 · Mechanisms of ageing and development

Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats.

Oita RC, Mazzatti DJ, Lim FL, Powell JR, Merry BJ

Dietary restriction increases Nr4a2 levels in the liver and muscle of rats, suggesting these genes help regulate metabolism rather than brain function. This finding does not provide direct insight into NR4A2-related neurodevelopmental syndromes or potential treatments for affected children.

  • Nr4a2 upregulation occurs in rat liver and muscle during dietary restriction.
  • Brain Nr4a2 levels do not change with dietary restriction in this model.
  • The study links NR4A receptors to metabolic adaptation, not neurological outcomes.
  • This preclinical animal data offers no direct clinical relevance for NR4A2 syndrome.
low2008-12-24 · The Journal of neuroscience : the official journal of the Society for Neuroscience

Lmx1b-controlled isthmic organizer is essential for development of midbrain dopaminergic neurons.

Guo C, Qiu HY, Shi M, Huang Y, Johnson RL, Rubinstein M, Chen SD, Ding YQ

This study shows that the Lmx1b gene is not required inside midbrain dopamine neurons for their survival, but it is essential in surrounding tissue to create the environment that allows these neurons to develop. Restoring this supportive environment rescues dopamine neuron development even when the Lmx1b gene is missing from the neurons themselves. This clarifies that Lmx1b acts as a structural organizer rather than a direct driver of dopamine neuron identity.

  • Lmx1b is not needed inside midbrain dopamine neurons for their differentiation or maintenance.
  • The loss of dopamine neurons in Lmx1b mutants results from disrupted tissue organization, not cell-autonomous failure.
  • Restoring the isthmic organizer environment rescues dopamine neuron development in mutant mice.
  • Lmx1b functions primarily to establish the midbrain-hindbrain boundary signals necessary for neuron formation.
low2008-12-18 · American journal of respiratory cell and molecular biology

Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity.

Shukla A, MacPherson MB, Hillegass J, Ramos-Nino ME, Alexeeva V, Vacek PM, Bond JP, Pass HI, Steele C, Mossman BT

Asbestos exposure alters gene expression in human mesothelial cells in a dose- and time-dependent way, with the gene ATF3 playing a key role in driving inflammation and growth factor production. The NR4A2 gene was also upregulated by asbestos in ovarian cells, but not in mesothelial cells.

  • Asbestos changes gene expression in human cells
  • ATF3 gene is highly activated by asbestos
  • ATF3 controls inflammatory cytokines and growth factors
  • NR4A2 increased in ovarian cells, not mesothelial cells
  • Nonfibrous particles like talc or TiO2 had minimal effects
low2008-12-13 · Neuroscience

Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.

Alladi PA, Mahadevan A, Yasha TC, Raju TR, Shankar SK, Muthane U

This study finds that nigral dopaminergic neurons in Asian Indians do not decline with age, unlike in other populations. The researchers observed stable neuron numbers and protein levels across a lifespan from gestation to old age. These findings suggest a biological basis for the lower incidence of Parkinson's disease in this demographic.

  • Nigral dopaminergic neurons remain stable in number and size throughout life in Asian Indians.
  • TH and Nurr1 protein expression levels do not decline with aging in this population.
  • No evidence of neuronal apoptosis was found in the substantia nigra of older subjects.
  • Results contrast with American cohorts where dopaminergic phenotype loss occurs from midlife.
low2008-12-06 · Journal of controlled release : official journal of the Controlled Release Society

Dexamethasone-pDMAEMA polymeric conjugates reduce inflammatory biomarkers in human intestinal epithelial monolayers.

Keely S, Ryan SM, Haddleton DM, Limer A, Mantovani G, Murphy EP, Colgan SP, Brayden DJ

Dexamethasone linked to a mucoadhesive polymer stays active and reduces inflammation in human gut cells, with the conjugate showing strong adhesion and no toxicity, suggesting potential for treating gut inflammation topically.

  • Dexamethasone-polymer conjugates reduce gut inflammation markers
  • Conjugates stick to gut cells and remain non-toxic
  • The drug stays active and is released slowly
  • Potential for topical treatment of intestinal inflammation
  • May help conditions involving gut inflammation
low2008-12-03 · Journal of neurophysiology

Glutamatergic nonpyramidal neurons from neocortical layer VI and their comparison with pyramidal and spiny stellate neurons.

Andjelic S, Gallopin T, Cauli B, Hill EL, Roux L, Badr S, Hu E, Tamás G, Lambolez B

This study characterizes the electrical and structural properties of specific neurons in rat brains, noting that a subset expresses Nurr1 mRNA. It finds no direct link between this genetic marker and how these neurons fire or look.

  • Researchers studied layer VI neurons in rat brain slices using electrophysiology and genetic markers.
  • Most nonpyramidal neurons in this layer are glutamatergic, not GABAergic.
  • A subset of these cells expresses Nurr1 mRNA, a marker for specific projection neurons.
  • Nurr1 expression does not correlate with the neurons' firing patterns or physical shape.
  • The study focuses on basic neuron classification without testing treatments or human outcomes.
low2008-12-01 · Anatomical science international

Visualization of spatiotemporal differentiation of dopaminergic interneurons in adult mouse olfactory bulb using transgenic mice.

Saino-Saito S

This study uses transgenic mice to track how dopamine-producing cells develop in the adult olfactory bulb. It finds that the gene Nurr1 (NR4A2) is active during this process, while other genes are not.

  • Researchers tracked dopamine cell development in adult mouse brains using genetic markers.
  • Nurr1 expression changes alongside dopamine production in these specific brain cells.
  • Other candidate genes did not show similar regulation patterns.
  • The study confirms Nurr1's role in regulating dopamine phenotypes in mice.
low2008-11-13 · Cerebral cortex (New York, N.Y. : 1991)

Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex.

Hoerder-Suabedissen A, Wang WZ, Lee S, Davies KE, Goffinet AM, Rakić S, Parnavelas J, Reim K, Nicolić M, Paulsen O, Molnár Z

This study identifies nuclear receptor-related 1 (NR4A2) as a specific marker for subplate neurons in the developing mouse brain. It confirms that NR4A2 expression helps distinguish different subpopulations of these early-developing cortical cells.

  • NR4A2 marks subplate neurons in the developing murine cerebral cortex.
  • The study uses mouse models to map NR4A2 expression patterns.
  • No human data or clinical findings are presented in this research.
  • The work focuses on basic developmental biology rather than treatment.
low2008-11-01 · Bulletin of experimental biology and medicine

High level of alpha-synuclein mRNA in peripheral lymphocytes of patients with alcohol dependence syndrome.

Taraskina AE, Filimonov VA, Kozlovskaya YA, Morozova MN, Gaschin DV, Schwarzman AL

People with alcohol dependence have higher levels of alpha-synuclein mRNA in their blood cells, but this does not relate to changes in the NR4A2 gene, which is important for dopamine neuron function.

  • Alpha-synuclein mRNA is elevated in blood cells of alcohol-dependent patients
  • No link found between alpha-synuclein levels and NR4A2 gene expression
  • NR4A2 remains unchanged despite alpha-synuclein increase
  • Findings may reflect broader neurobiological changes in alcohol dependence
low2008-10-27 · PloS one

Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo.

Andersson ER, Prakash N, Cajanek L, Minina E, Bryja V, Bryjova L, Yamaguchi TP, Hall AC, Wurst W, Arenas E

Wnt5a signaling guides the development of dopamine-producing neurons by regulating their shape, division, and maturation in the midbrain. Disruption of this pathway causes structural defects in the brain and delays the differentiation of NR4A2-positive precursor cells into functional neurons.

  • Wnt5a activates Rac1 to drive the differentiation of dopaminergic precursors.
  • Mice lacking Wnt5a show delayed maturation of NR4A2+ precursor cells.
  • The absence of Wnt5a causes structural defects in midbrain elongation.
  • Excess precursors remain undifferentiated until later developmental stages.
low2008-10-22 · Molecular endocrinology (Baltimore, Md.)

Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.

Chao LC, Bensinger SJ, Villanueva CJ, Wroblewski K, Tontonoz P

This study shows that NR4A family proteins (Nur77, Nurr1, and Nor1) block the development of fat cells in laboratory mouse cell lines. The researchers identify specific genes and mechanisms by which these proteins inhibit adipocyte differentiation, but they do not investigate brain function or neurological symptoms.

  • NR4A proteins inhibit fat cell formation in mouse preadipocyte cell lines.
  • Nur77 expression increases with inflammatory signals and fasting/refeeding cycles.
  • The inhibition mechanism involves blocking mitotic clonal expansion of cells.
  • Gap-junction protein alpha1 and tolloid-like 1 mediate the anti-adipogenic effects.
  • This effect cannot be reversed by activating PPAR-gamma receptors.
low2008-10-21 · Neurotoxicology and teratology

Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels.

Eells JB, Brown T

Developmental exposure to the insecticides chlorpyrifos and methyl parathion alters dopamine metabolism and nicotinic acetylcholine receptor expression in rat brains. These changes persist into adulthood, suggesting that early-life pesticide exposure can have long-lasting effects on dopaminergic systems.

  • Chlorpyrifos increases dopamine metabolite levels in adult rats after developmental exposure.
  • Both pesticides alter nicotinic acetylcholine receptor subunit ratios in the substantia nigra.
  • The study uses a rat model, not human participants or NR4A2 genetics.
  • No direct link to NR4A2-related syndrome mechanisms is established.
low2008-10-15 · Journal of cellular biochemistry

Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1.

Ohkura N, Nagamura Y, Tsukada T

The fusion protein EWS/NOR1, found in a rare bone cancer, acts differently than the normal NOR1 protein by escaping regulation from a cellular brake called PARP-1. This allows EWS/NOR1 to turn on genes in a way that may drive cancer, while normal NOR1 is kept in check. The difference lies in how these proteins interact with other molecules, especially PARP-1.

  • EWS/NOR1 avoids PARP-1 repression, unlike normal NOR1
  • PARP-1 acts as a brake on NOR1 activity
  • This difference may explain why EWS/NOR1 causes cancer
  • The NR4A family of proteins is regulated by PARP-1 in a gene-specific way
  • EWS/NOR1 gains oncogenic power by escaping normal controls
low2008-10-15 · Molecular human reproduction

Chemically defined sequential culture media for TH+ cell derivation from human embryonic stem cells.

Song T, Chen G, Wang Y, Mao G, Wang Y, Bai H

Researchers developed a reliable method to generate dopamine-producing neurons from human embryonic stem cells that survive and function in Parkinson's disease rat models. These cells release dopamine and reduce motor symptoms when transplanted into rats, demonstrating potential for future cell therapies.

  • Protocol produces over 90% tyrosine hydroxylase-positive cells from human embryonic stem cells.
  • Derived cells release dopamine in response to stimulation in laboratory settings.
  • Transplanted cells survive and reduce motor deficits in Parkinson's disease rat models.
  • Study focuses on cell therapy for Parkinson's, not NR4A2 genetic syndromes.
low2008-10-15 · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Target identification for CNS diseases by transcriptional profiling.

Altar CA, Vawter MP, Ginsberg SD

This review summarizes gene expression changes in various neuropsychiatric and neurodegenerative disorders to identify potential drug targets. It highlights pathways involving dopamine, glutamate, and neurotrophic factors that are altered in conditions like Parkinson's disease, Alzheimer's disease, and schizophrenia.

  • The paper reviews transcriptional profiling data from human brains, animal models, and cell cultures.
  • It identifies potential drug targets for Alzheimer's, Parkinson's, schizophrenia, bipolar disorder, and depression.
  • Nurr1 is mentioned as a downstream target in Parkinson's disease pathways.
  • The study does not focus on NR4A2-related syndrome or specific treatments for it.
  • Most findings are general mechanisms rather than specific insights for this child's condition.
low2008-10-11 · Biochemical and biophysical research communications

Expression of dopamine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells.

Nadri S, Soleimani M, Mobarra Z, Amini S

Researchers demonstrate that stem cells derived from human eye tissue can be converted into dopamine-producing neurons in a laboratory dish. This finding suggests these specific cells could potentially serve as a source for cell replacement therapies in neurodegenerative diseases like Parkinson's.

  • Stem cells from the conjunctiva of the eye were successfully isolated and cultured.
  • These cells differentiated into neurons expressing key dopamine-related genes and proteins.
  • The study proposes these cells as a viable source for future transplant therapies.
low2008-10-07 · Progress in neuro-psychopharmacology & biological psychiatry

mRNA expression of the Nurr1 and NGFI-B nuclear receptor families following acute and chronic administration of methamphetamine.

Akiyama K, Isao T, Ide S, Ishikawa M, Saito A

This rat study shows that methamphetamine exposure alters the expression of Nurr1 and NGFI-B genes in specific brain regions, with effects differing between acute and chronic drug use. These findings describe molecular changes in animal models of addiction rather than providing insights into NR4A2-related syndromes or potential treatments for children.

  • Methamphetamine increases Nurr1 mRNA in rat cortex and VTA within hours of administration.
  • Chronic meth use leads to persistent changes in Nurr1 and NGFI-B gene expression during withdrawal.
  • Acute meth challenge fails to further increase these genes in chronically exposed rats.
  • The study focuses on addiction mechanisms in rodents, not human genetic syndromes.
  • No clinical relevance or treatment implications for NR4A2-related conditions are identified.
low2008-10-01 · Synapse (New York, N.Y.)

Alterations in amphetamine-stimulated dopamine overflow due to the Nurr1-null heterozygous genotype and postweaning isolation.

Moore TM, Brown T, Cade M, Eells JB

A single missing copy of the Nurr1 gene causes subtle dopamine changes alone, but combined with early-life social isolation, it dramatically disrupts dopamine signaling in brain reward pathways. This interaction between genetics and environment suggests that developmental stressors can significantly worsen dopamine dysfunction in individuals with NR4A2 variants.

  • Isolation reduces dopamine overflow in healthy mice but increases it in Nurr1-mutant mice.
  • Nurr1 mutation alone causes only minor, often insignificant changes to basal dopamine levels.
  • The combination of genetic risk and environmental stress creates large differences in dopamine function.
  • This model links specific gene-environment interactions to potential behavioral disorders.
low2008-10-01 · Development (Cambridge, England)

Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon.

Omodei D, Acampora D, Mancuso P, Prakash N, Di Giovannantonio LG, Wurst W, Simeone A

This study identifies Otx2 as a critical regulator that controls the growth and maturation of dopamine-producing neuron precursors in the developing brain. The research demonstrates that precise levels of Otx2 are necessary to prevent premature differentiation and ensure proper proliferation of these cells.

  • Otx2 regulates the balance between progenitor cell division and maturation into dopamine neurons.
  • Lack of Otx2 causes precursors to stop dividing and differentiate too early.
  • Excess Otx2 increases the number of dopamine neuron precursors in a dose-dependent manner.
  • The study uses mouse mutants to establish these developmental mechanisms.
  • Findings suggest Otx2 could be a target for cell replacement therapies in Parkinson's disease.
low2008-09-25 · PloS one

Analysis of area-specific expression patterns of RORbeta, ER81 and Nurr1 mRNAs in rat neocortex by double in situ hybridization and cortical box method.

Hirokawa J, Watakabe A, Ohsawa S, Yamamori T

This study maps the spatial distribution of Nurr1 mRNA in the rat neocortex to understand normal brain development. It confirms that Nurr1 expression is distinct from other layer-specific markers and correlates with cortical functional areas. The findings provide basic anatomical data on where this gene is active in a healthy rodent brain.

  • Nurr1 mRNA expression patterns are unique and mostly complementary to RORbeta and ER81 in rat cortex.
  • Nurr1 does not co-localize with ER81 at the single-cell level in layer 5 neurons.
  • Gene expression profiles correlate with the hierarchical processing order of cortical areas.
  • The study validates a new method for integrating gene expression data into 3D brain maps.
  • Results describe normal anatomy in rats, not disease mechanisms or treatments.